Search research articles
Contact Us
Filters
Showing results (21-30 of 261) with videos related to
Page
of 27
Sort By:
Drug Testing and Analysis
|
August 23, 2022
Analytical toxicology of yew constituents in human blood and urine by liquid chromatography-high-resolution tandem mass spectrometry
Cathy M Jacobs, Lea Wagmann, Markus R Meyer
Toxicology Letters
|
March 29, 2014
Toxicokinetics of novel psychoactive substances: characterization of N-acetyltransferase (NAT) isoenzymes involved in the phase II metabolism of 2C designer drugs
Markus R Meyer, Anja Robert, Hans H Maurer
Analytical and Bioanalytical Chemistry
|
January 31, 2021
Development, validation, and application of a quantitative volumetric absorptive microsampling-based method in finger prick blood by means of LC-HRMS/MS applicable for adherence monitoring of antipsychotics
Cathy M Jacobs, Lea Wagmann, Markus R Meyer
Therapeutic Drug Monitoring
|
February 17, 2022
New Psychoactive Substances: Which Biological Matrix Is the Best for Clinical Toxicology Screening?
Lea Wagmann, Cathy M Jacobs, Markus R Meyer
Drug Testing and Analysis
|
January 11, 2013
Studies on the metabolism and detectability of the designer drug β-naphyrone in rat urine using GC-MS and LC-HR-MS/MS
Markus R Meyer, Denise Prosser, Hans H Maurer
Toxicology Letters
|
January 1, 2013
Michaelis-Menten kinetic analysis of drugs of abuse to estimate their affinity to human P-glycoprotein
Markus R Meyer, Tina Orschiedt, Hans H Maurer
Toxicology Letters
|
December 7, 2013
Dimethocaine, a synthetic cocaine derivative: studies on its in vitro metabolism catalyzed by P450s and NAT2
Markus R Meyer, Carina Lindauer, Hans H Maurer
Journal of Analytical Toxicology
|
June 8, 2021
Can the Intake of a Synthetic Tryptamine be Detected Only by Blood Plasma Analysis? A Clinical Toxicology Case Involving 4-HO-MET
Lea Wagmann, Sascha K Manier, Markus R Meyer
Analytical and Bioanalytical Chemistry
|
April 1, 2021
Recent trends in drugs of abuse metabolism studies for mass spectrometry-based analytical screening procedures
Lea Wagmann, Tanja M Gampfer, Markus R Meyer
Therapeutic Drug Monitoring
|
October 6, 2023
Sample Matrices for Mass Spectrometry-Based Adherence Monitoring: A Systematic Critical Review
Cathy M Jacobs, Lea Wagmann, Markus R Meyer
Page
of 27
Search research articles
Search
Showing results (21-30 of 261) with videos related to
Sort By:
Page
of 27
Drug Testing and Analysis
|
August 23, 2022
Analytical toxicology of yew constituents in human blood and urine by liquid chromatography-high-resolution tandem mass spectrometry
Cathy M Jacobs, Lea Wagmann, Markus R Meyer
Toxicology Letters
|
March 29, 2014
Toxicokinetics of novel psychoactive substances: characterization of N-acetyltransferase (NAT) isoenzymes involved in the phase II metabolism of 2C designer drugs
Markus R Meyer, Anja Robert, Hans H Maurer
Analytical and Bioanalytical Chemistry
|
January 31, 2021
Development, validation, and application of a quantitative volumetric absorptive microsampling-based method in finger prick blood by means of LC-HRMS/MS applicable for adherence monitoring of antipsychotics
Cathy M Jacobs, Lea Wagmann, Markus R Meyer
Therapeutic Drug Monitoring
|
February 17, 2022
New Psychoactive Substances: Which Biological Matrix Is the Best for Clinical Toxicology Screening?
Lea Wagmann, Cathy M Jacobs, Markus R Meyer
Drug Testing and Analysis
|
January 11, 2013
Studies on the metabolism and detectability of the designer drug β-naphyrone in rat urine using GC-MS and LC-HR-MS/MS
Markus R Meyer, Denise Prosser, Hans H Maurer
Toxicology Letters
|
January 1, 2013
Michaelis-Menten kinetic analysis of drugs of abuse to estimate their affinity to human P-glycoprotein
Markus R Meyer, Tina Orschiedt, Hans H Maurer
Toxicology Letters
|
December 7, 2013
Dimethocaine, a synthetic cocaine derivative: studies on its in vitro metabolism catalyzed by P450s and NAT2
Markus R Meyer, Carina Lindauer, Hans H Maurer
Journal of Analytical Toxicology
|
June 8, 2021
Can the Intake of a Synthetic Tryptamine be Detected Only by Blood Plasma Analysis? A Clinical Toxicology Case Involving 4-HO-MET
Lea Wagmann, Sascha K Manier, Markus R Meyer
Analytical and Bioanalytical Chemistry
|
April 1, 2021
Recent trends in drugs of abuse metabolism studies for mass spectrometry-based analytical screening procedures
Lea Wagmann, Tanja M Gampfer, Markus R Meyer
Therapeutic Drug Monitoring
|
October 6, 2023
Sample Matrices for Mass Spectrometry-Based Adherence Monitoring: A Systematic Critical Review
Cathy M Jacobs, Lea Wagmann, Markus R Meyer
Page
of 27